Groupe Francophone Des Myelodysplasies

This study tests a combination of two drugs (venetoclax and azacitidine) plus donor immune cells in people whose MDS or AML came back after a stem cell transplant. The goal is to find the best dose and see if the treatment can control the cancer. About 55 adults with relapsed dis…

This study is a registry that tracks 400 patients aged 70 or younger with a low-risk form of acute promyelocytic leukemia (APL). It compares two standard first-line treatments—ATRA plus chemotherapy versus ATRA plus arsenic trioxide—to see which works better and has fewer side ef…